Mann D M
Department of Pathology, University of Manchester, U.K.
Mech Ageing Dev. 1988 May;43(2):99-136. doi: 10.1016/0047-6374(88)90041-3.
The neuropathology of Down syndrome (DS) at middle age is compared with that of Alzheimer disease (AD) at that age, through a review of the published literature and from the author's personal observations on brains from a series of patients of different ages with DS. It is noted that the pathological changes of DS at middle age (i.e. the form and distribution of senile plaques and neurofibrillary tangles, the pattern of involvement (atrophy) of neuronal systems) are qualitatively the same as those of AD at that age, though quantitative differences do occur and these may relate to biological or sociological variations inherent to the two parent populations. It is concluded that in pathological terms patients with DS at middle age do indeed have AD. Some ways in which a study of patients with DS can give insight into the nature and development of the pathological changes of AD are put forward and discussed.
通过回顾已发表的文献以及作者对一系列不同年龄段唐氏综合征(DS)患者大脑的个人观察,将中年唐氏综合征(DS)的神经病理学与该年龄段阿尔茨海默病(AD)的神经病理学进行了比较。值得注意的是,中年DS的病理变化(即老年斑和神经原纤维缠结的形式和分布、神经系统受累(萎缩)模式)在性质上与该年龄段AD的病理变化相同,尽管存在数量差异,这些差异可能与两个母群体固有的生物学或社会学差异有关。得出的结论是,从中年DS患者的病理学角度来看,他们确实患有AD。文中提出并讨论了一些通过研究DS患者来深入了解AD病理变化的性质和发展的方法。